Literature DB >> 29065258

Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based study.

Jaya Benjamin1, Varsha Shasthry1, Chetan Ramesh Kaal2, Lovkesh Anand2, Ankit Bhardwaj3, Vanshja Pandit1, Ankur Arora4, Sasidharan Rajesh4, Viniyendra Pamecha5, Vikas Jain6, Guresh Kumar3, Anthony Loria7, Puneet Puri7, Yogendra Kumar Joshi1, Shiv Kumar Sarin2.   

Abstract

BACKGROUND: Alterations in body composition (BC) as loss of fat and muscle mass (sarcopenia) are associated with poor outcome in alcoholic cirrhosis (ALC). Prevalence of sarcopenia depends upon the method of assessment. Computed Tomography (CT) is a gold standard tool for assessing BC. AIM: To characterize BC and define sarcopenia in ALC patients using CT.
METHODS: Single slice CT images at L3 vertebrae of healthy controls (HC) - organ transplant donors and ALC patients were analysed to give cross-sectional area of five skeletal muscles normalized for height -skeletal muscle index (SMI; cm2 /m2 ), area of subcutaneous (SAT;cm2 ) and visceral adipose tissue (VAT;cm2 ). Cut-offs for defining sarcopenia was established at 2SD below the mean of HC. HC were compared with Child A-compensated (C) and Child B+C-decompensated (DC) patients.
RESULTS: Cut-offs of SMI derived from HC (n = 275; M: 50%; age 32.2 ± 9.8 years; BMI 24.2 ± 3.2 Kg/m2 ) were 36.54 in males and 30.21 in females. Sarcopenia was found in 12.8% of ALC patients [n = 148; C (31.8%): DC (68.2%); M: 100%; age 46.6 ± 9.7 years; BMI 24.5 ± 4.4]. Compared to HC, compensated patients had higher adiposity and comparable muscularity; decompensated patients had significantly lower muscle and also fat mass compared to both HC and compensated patients. HC vs C vs DC: SAT (140 ± 82 vs 177.3 ± 11 vs 112 ± 8.2); VAT (96.5 ± 6.5 vs 154.9 ± 8.7 vs 87.5 ± 6.5) and SMI (52.1 ± 0.9 vs 49.6 ± 1.2 vs 46 ± 0.9).
CONCLUSIONS: Compensated ALC have increased adiposity and relatively preserved muscularity but decompensation leads to loss of both muscle and fat mass. Prevalence of sarcopenia, based on derived ethnic cut-offs was 12.8%.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Asian Indian; chronic liver disease; nutritional status; skeletal muscle area; subcutaneous fat; visceral fat

Mesh:

Year:  2017        PMID: 29065258     DOI: 10.1111/liv.13509

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  15 in total

1.  A Pilot Study of Racial Differences in the Current Definition of Sarcopenia among Liver Transplant Candidates.

Authors:  Tomoki Sempokuya; Leigh Yokoyama-Arakaki; Linda L Wong; Sumodh Kalathil
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01

Review 2.  Nutritional screening and assessment in inflammatory bowel disease.

Authors:  Arshdeep Singh; Catherine Wall; Arie Levine; Vandana Midha; Ramit Mahajan; Ajit Sood
Journal:  Indian J Gastroenterol       Date:  2022-01-15

3.  Untangling the Web of Malnutrition, Sarcopenia, and Frailty in Chronic Liver Disease.

Authors:  Vivek A Saraswat; Karan Kumar
Journal:  J Clin Exp Hepatol       Date:  2022-03-17

4.  A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis.

Authors:  Surender Singh; Sunil Taneja; Puneeta Tandon; Akash Bansal; Ujjwal Gorsi; Akash Roy; Arka De; Nipun Verma; Madhumita Premkumar; Ajay Duseja; Radha K Dhiman; Virendra Singh
Journal:  J Clin Exp Hepatol       Date:  2021-07-21

5.  Alterations in Autophagy and Mammalian Target of Rapamycin (mTOR) Pathways Mediate Sarcopenia in Patients with Cirrhosis.

Authors:  Abhinav Anand; Aruna Nambirajan; Vikas Kumar; Samagra Agarwal; Sanchit Sharma; Srikant Mohta; Srikanth Gopi; Kanav Kaushal; Deepak Gunjan; Namrata Singh; Kumble S Madhusudhan; Shyam S Chauhan; Mehar C Sharma; Virinder K Bansal; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2021-05-21

6.  Relevance of Population-Based Cutoffs to Define Sarcopenia in Clinical Studies.

Authors:  Shweta A Singh; Kaushal Madan; Ruchi Rastogi; Abhishek R Agarwal; Subhash Gupta; Ruchika Thakur
Journal:  J Clin Exp Hepatol       Date:  2020-10-08

7.  European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis.

Authors:  Abhinav Anand; Srikant Mohta; Samagra Agarwal; Sanchit Sharma; Srikanth Gopi; Deepak Gunjan; Kumble S Madhusudhan; Namrata Singh; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2021-04-08

8.  Apparent Diffusion Coefficient Is a Novel Imaging Biomarker of Myopathic Changes in Liver Cirrhosis.

Authors:  Alexey Surov; Lisa Paul; Hans Jonas Meyer; Stefan Schob; Cornelius Engelmann; Andreas Wienke
Journal:  J Clin Med       Date:  2018-10-15       Impact factor: 4.241

9.  Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis.

Authors:  Chisato Saeki; Tomoya Kanai; Masanori Nakano; Tsunekazu Oikawa; Yuichi Torisu; Masayuki Saruta; Akihito Tsubota
Journal:  JGH Open       Date:  2021-05-29

10.  Reference Values for Skeletal Muscle Mass at the Third Lumbar Vertebral Level Measured by Computed Tomography in a Healthy Korean Population.

Authors:  Ja Kyung Yoon; Sunyoung Lee; Kyoung Won Kim; Ji Eun Lee; Jeong Ah Hwang; Taeyong Park; Jeongjin Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.